08.02.2021 Views

09-02-2021

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

TueSDAY, FeBruArY 9, 2021

7

In this Nov. 30, 2020 file photo, volunteers wait to be checked at a vaccine trial facility set at Soweto's

Chris Sani Baragwanath Hospital outside Johannesburg, South Africa. South Africa suspended plans

Sunday Feb. 7, 2021 to inoculate its front-line health care workers with the AstraZeneca vaccine after a

small clinical trial suggested that it isn't effective in preventing mild to moderate illness from the variant

dominant in the country.

Photo : AP

South Africa suspends Astra

Zeneca vaccine drive

JOHANNESBURG : South Africa has

suspended plans to inoculate its frontline

health care workers with the

Oxford-AstraZeneca vaccine after a

small clinical trial suggested that it isn't

effective in preventing mild to moderate

illness from the variant dominant in

the country.

South Africa received its first 1 million

doses of the AstraZeneca vaccine

last week and was expected to begin

giving jabs to health care workers in

mid-February. The disappointing early

results indicate that an inoculation

drive using the AstraZeneca vaccine

may not be useful, reports UNB.

Preliminary data from a small study

suggested that the AstraZeneca vaccine

offers only "minimal protection against

mild-moderate disease" caused by the

variant in South Africa. The variant

appears more infectious and is driving

a deadly resurgence of the disease in

the country, currently accounting for

more than 90% of the COVID-19 cases,

health minister Zweli Mkhize said

Sunday night.

"The AstraZeneca vaccine appeared

effective against the original strain, but

not against the variant," Mkhize said.

"We have decided to put a temporary

hold on the rollout of the vaccine ...

more work needs to be done."

The study, which hasn't yet been

peer-reviewed, involved 2,000 people,

most of whom were young and healthy.

The volunteers' average age was 31.

Death toll from India's

glacier tragedy rises to

14, over 200 missing

NEW DELHI : The death

toll in Sunday's glacier

burst in north India has

risen to 14, even as the

number of missing persons

swelled to over 200, confirmed

official sources on

Monday.

The natural disaster hit

the country's northern hilly

state of Uttarakhand on

Sunday morning, severely

damaging two hydro power

projects.

Among the missing persons

are 11 local villagers

and around 190 workers

employed at two power

projects.

"Most of the missing

persons are said to be

labourers hailing from the

eastern state of Bihar and

northern state of Uttar

Pradesh," the India Today

media group quoted

Uttarakhand Director

General of Police (DGP)

Ashok Kumar as saying.

According to Kumar, the

rescue work is focussed on a

1,800-meter long tunnel

where around 35 to 40 people,

mostly power project

labourers, are feared

trapped. The tunnel is said

to be filled with several feet

high slush and debris.

Meanwhile, according to

sources at the local disaster

management office, 13 villages

have been cut off due

to the natural disaster, and

efforts are being made to

reach out to them with food

and medical aid.

"Protection against moderate-severe

disease, hospitalization or death could

not be assessed in this study as the target

population were at such low risk,"

said a statement issued by Oxford

University and the University of the

Witwatersrand in Johannesburg.

Scientists will be studying whether or

not the AstraZeneca vaccine is effective

in preventing severe disease and death

against the variant, Mkhize said.

Other vaccines have shown reduced

efficacy against the variant, but have

provided good protection from serious

disease and death.

Public health officials are concerned

about the South Africa variant because

it contains a mutation of the virus'

characteristic spike protein, which is

targeted by existing vaccines. South

African officials say the variant is more

contagious and evidence is emerging

that it may be more virulent.

South Africa will urgently roll out

other vaccines to inoculate as many as

possible in the coming months, Mkhize

said. Other South African scientists on

Sunday said the clinical trials for the

Johnson and Johnson vaccine show

good results against the variant.

The early results for the AstraZeneca

vaccine against the variant could have

far-reaching implications as many

other countries in Africa and beyond

have been planning to use the

AstraZeneca shot. The international

COVAX initiative has bought the

AstraZeneca vaccine in bulk from the

Serum Institute of India.

Developers of the Oxford-

AstraZeneca vaccine expect to have a

modified jab to cope with the South

Africa coronavirus variant by autumn,

the vaccine's lead researcher said

Sunday.

Sarah Gilbert, lead researcher for the

Oxford team, told the BBC on Sunday

that "we have a version with the South

African spike sequence in the works."

"It looks very likely that we can have

a new version ready to use in the

autumn," she added.

Authorities in England last week

went house-to-house to administer

COVID-19 testing in eight areas where

the South Africa variant is believed to

be spreading, after a handful of cases

were found in people who had no contact

with the country or anyone who

traveled there.

More than 100 cases of the South

African variant have been found in the

U.K. The testing blitz is a bid to snuff

out the variant before it spreads widely

and undermines the U.K.'s vaccination

rollout.

Britain has seen Europe's deadliest

coronavirus outbreak, with over

112,000 confirmed deaths, but it has

embarked on a speedier vaccination

plan than the neighboring European

Union. So far, the U.K. has given a first

coronavirus vaccine jab to about 11.5

million people.

Week after military coup, protests

swell rapidly in Myanmar

YANGON : A protest against Myanmar's oneweek-old

military government swelled rapidly

Monday morning as opposition to the coup

grew increasingly bold, reports UNB.

The protesters at a major downtown

Yangon intersection chanted slogans, raised a

three-finger salute and carried placards saying

"Reject the military coup" and "Justice for

Myanmar." Starting with a few hundred people,

the crowd exceeded a thousand by midmorning

and cars passing by honked their

horns in solidarity.

Some smaller groups broke off from the

main protest and headed to the Sule Pagoda,

a past rallying point for major protests

against previous ruling juntas. Monday's

action followed a protest Sunday involving

tens of thousands of people demonstrating to

demand the release of deposed leader Aung

San Suu Kyi and other top figures from her

National League for Democracy party.

The growing protests are a sharp reminder

of the long and bloody struggle for democracy

in a country that the military ruled directly

for more than five decades before loosening

its grip in 2012. Suu Kyi's government, which

won a landslide election in 2015, was the first

led by civilians in decades, though its power

was limited by a military-drafted constitution.

During Myanmar's years of isolation

under military rule, the golden-domed Sule

Pagoda served as a rallying point for political

protests calling for democracy, most notably

in during a massive 1988 uprising and again

during a 2007 revolt led by Buddhist monks.

The military used deadly force to end both

of those uprisings, with estimates of hundreds

if not thousands killed in 1988. While

riot police have watched the protests this past

week, soldiers have been absent and there

have been no reports of clashes. Several

videos posted online Sunday that were said to

be from the town of Myawaddy, on

Myanmar's eastern border with Thailand,

showed police shooting into the air in an evident

effort to disperse a crowd.

The death toll in Sunday's glacier burst in north India has risen to 14, even

as the number of missing persons swelled to over 200, confirmed official

sources on Monday.

Photo : AP

The Latest: China's

northeast outbreaks

appear under control

BEIJING : China appears to

have stamped out its latest

coronavirus outbreaks centered

on the northeast,

reporting no new cases of

local infection in its latest

daily report.

The National Health

Commission said Monday

that 14 newly confirmed

cases had been brought from

outside the country but no

new cases were registered in

the provinces of

Heilongjiang and Jilin that

have seen China's latest clusters.

While China has relaxed

some social distancing rules,

extensive testing, electronic

monitoring and periodic

lockdowns remain in place.

The country has reported

4,636 deaths among almost

90,000 cases since the coronavirus

was first detected in

the central Chinese city of

Wuhan in December 2019.

The UK's aggressive vaccine

gambles have paid off,

while EU caution is slowing

down its vaccination program.

The West African

country of Burkina Faso,

which at first managed to

avoid a catastrophic surge of

the coronavirus, is now trying

to cope with a much

deadlier resurgence.

Biden foresees 'extreme

competition' with

China, not 'conflict'

WASHINGTON : President

Joe Biden anticipates the

US rivalry with China will

take the form of "extreme

competition" rather than

conflict between the two

world powers.

Biden said in an excerpt of

a CBS interview aired

Sunday that he has not spoken

with Chinese counterpart

Xi Jinping since he

became US president.

"He's very tough. He doesn't

have - and I don't mean it

as a criticism, just the reality

- he doesn't have a democratic,

small D, bone in his

body," Biden said.

"I've said to him all along,

that we need not have a conflict.

But there's going to be

extreme competition,"

Biden said.

"I'm not going to do it the

way (Donald) Trump did.

We're going to focus on

international rules of the

road."

China is considered in

Washington as the United

States' number one strategic

adversary, and the primary

challenge on the world

stage.

Trump had chosen open

confrontation and verbal

attacks, without serious tangible

results for the enormous

US trade deficit with

China.

Palestinians launch

postcodes in assertion

of sovereignty

RAMALLAH : The

Palestinian Authority

announced Sunday it would

begin using its own postal

codes, a move at easing the

delivery of parcels in the

occupied territories as well

as asserting sovereignty.

International mail sent to

or from the occupied West

Bank currently has to pass

through Jordan or Israel.

But the PA said Sunday it

had asked the Universal

Postal Union to notify its

member states that

Palestinian postal codes

were coming into force.

"From April, postal items

that do not bear a

Palestinian postal code will

not be processed,"

Palestinian Minister of

Communications Ishaq

Sidr told reporters in

Ramallah, the West Bank

headquarters of the

Palestinian Authority.

"It is a question of asserting

Palestinian rights," he

said.

Palestinian postal codes

would also help put an end

to the seizure of shipments

from abroad, Sidr said.

UK vaccine gambles paid off, while

EU caution slowed it down

SAINT-HERBLAIN : French pharmaceutical

startup Valneva had big news in

September: a government contract for 60

million doses of its coronavirus vaccine

candidate.

The buyer? The United Kingdom - not

the European Union, as might be expected

for a company on the banks of the Loire,

reports UNB.

"What a true waste," bristled Christelle

Morancais, president of the Pays de la

Loire regional council, as she tried to wrap

her head around the missed opportunity.

The British, she told The Associated Press,

"rolled out the red carpet for this company,

helping with financing and the set-up. ...

And we were powerless."

The U.K. has now ordered another 40

million doses and has options for more

from Valneva, which has a plant in

Scotland. The EU is still in talks with the

company.

That pattern of Britain investing aggressively

and early while the EU takes a slower,

more cautious approach has been the

hallmark of the vaccine race in Europe -

and offers a window into problems that

have dogged the vaccination rollout by the

world's biggest trading bloc.

As with other countries that moved

quickly, negotiating contracts earlier has

helped Britain avoid some of the vaccine

supply problems the 27-nation EU has

faced - as when AstraZeneca said it hit a

production issue. Valneva President

Franck Grimaud told the AP that Britain

will receive vaccine doses earlier because it

signed first.

But the U.K. has also shown speed and

agility in other areas: Its regulatory agency

has authorized vaccines more quickly than

the EU's, and its government has experimented

with stretching out the time

between shots - allowing it to roll out first

doses faster so more people can have some

protection quickly.

The EU has been more cautious on both

counts. While bloc is still getting and distributing

vaccine - unlike much of the

world - it has so far been left in the U.K.'s

rearview mirror. Britain has given at least

one shot to about 15% of its population,

compared to some 3% in the bloc. This is

not only a matter of pride: The EU has

already lost more than 490,000 out of its

450 million people to the pandemic,

according to Johns Hopkins University,

and uncounted others who were not tested

before they died.

Diane Wanten, from Alken, Belgium,

survived a bout with COVID-19 that put

her in intensive care last spring. The 62-

year-old now badly hopes for shots for herself

and her husband Francesco, who has

Parkinson's. "If there is a vaccine for me

tomorrow, I'll be in line," she said.

Instead, "it is Britain which is towering

head and shoulders above the rest,"

Wanten said. "I keep asking myself why

things are possible there and not here in

Belgium?"

Britain has its own struggles: a death toll

of 112,000 in a country of 67 million and

plenty who say the Conservative government

should have moved faster to fight the

virus. Still, it celebrated the Valneva contract

as validation of its vaccine strategy -

and its decision to leave the EU.

French pharmaceutical startup Valneva had big news in September: a

government contract for 60 million doses of its coronavirus vaccine

candidate.

Photo : AP

Gunmen kill 19 in village

raids on northwest Nigeria

KANO, Nigeria : Nineteen people were killed

at the weekend when armed men raided two

villages in northwest Nigeria's Kaduna state,

the government said, in the latest violence to

hit the region.

Gunmen from kidnapping and cattle

rustling gangs - called bandits by locals - often

raid villages in northwest Nigeria, stealing cattle,

kidnapping for ransom and burning

homes after looting supplies.

"Kaduna State Government has received

reports from security agencies of the killing of

19 citizens in Birnin Gwari and Kajuru local

government areas," Samuel Aruwan, internal

affairs commissioner said in a statement.

"The citizens were killed by armed bandits

at Kutemeshi village in Birnin Gwari and

Kujeni village in Kajuru, where several others

were left with bullet wounds," Aruwan said.

Late on Saturday, bandits riding on motorcycles

killed 14 people and injured others

when they invaded Kutemeshi where they

looted shops, the official said.

On the same day motorbike-riding gunmen

also stormed Kujeni where they killed five

people and burnt "several" houses, warehouses

and a church, said Aruwan in the statement.

But residents said 19 people were killed just

in the raid in Kutemeshi.

"We lost 19 people in the attack. We buried

them yesterday (Sunday)," said Kutemeshi

resident Ayuba Abdullahi.

Last month bandits killed 12 people and kidnapped

30 others in attacks on three villages in

Birnin Gwari district and neighbouring

Katsina state.

Kidnapping and cattle rustling gangs maintain

camps in the Rugu forest straddling

Kaduna, Katsina, Zamfara and Niger states.

The gangs have no ideological leanings but

there are concerns that the gangs may be gradually

infiltrated by jihadists from the northeast.

Violence across the northwest has killed

8,000 people since 2011 and displaced more

than 200,000, some into neighbouring Niger,

according to a report last year by the

International Crisis Group (ICG).

In Iran standoff, Biden says US

won't unilaterally lift sanctions

WASHINGTON : US President Joe Biden has

made clear he will not unilaterally lift sanctions

against Iran, saying it must first adhere to its

nuclear deal commitments despite demands

on Sunday from the Islamic Republic's

supreme leader.

The exchange underscored the thorny diplomatic

challenge ahead as Biden seeks to revive

- without showing weakness - a key accord

rejected by his predecessor Donald Trump.

Asked in a CBS interview airing Sunday

whether he would halt sanctions to convince

Iran to return to the bargaining table, Biden

offered a clear reply: "No."

The journalist then asked if the Iranians

would first have to stop enriching uranium,

which drew an affirmative nod from Biden.

The clip was part of a longer interview to be

aired later Sunday on CBS.

The landmark deal was reached in 2015 by

the United States and other powers (China,

Russia, Germany, France and Britain) following

long negotiations with Iran aimed at preventing

it from developing nuclear weapons.

The deal has been hanging by a thread since

Trump's decision to withdraw from it in 2018

and reimpose sanctions on Tehran.

Trump argued that the accord did not sufficiently

restrict Iran's nuclear program and he

complained of its "destabilizing" activities in

the region.

Trump resumed the US sanctions on Tehran

that had been lifted through the accord, and he

pressed reluctant allies to do the same. Tehran

a year later suspended its compliance with

most key nuclear commitments.

The Biden administration has expressed

willingness to return to the deal, but insisted

that Tehran first resume full compliance.

On January 4, Iran announced it has stepped

up its uranium enrichment process to 20 percent

purity, far above the 3.67 percent level

permitted by the deal, but far below the

amount required for an atomic bomb.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!